Smartlens, Inc.

About Smartlens, Inc.

Smartlens Inc. is dedicated to transforming anterior segment disease management in ophthalmic care. Their mission is to address critical unmet needs in continuous monitoring, diagnosis, and treatment optimization, with a focus on intraocular pressure (IOP) for glaucoma and other conditions. By integrating novel microfluidic technology and AI-enhanced diagnostics, they aim to enable precise, real-time tracking and personalized care, shifting from episodic to continuous, data-driven treatment to improve outcomes and access to specialist care.

Products & Services

miLens™:A non-invasive, electronics-free contact lens for remote intraocular pressure (IOP) monitoring. It captures critical pressure variations for early detection of IOP spikes, using the world's smallest wearable microfluidic device paired with an AI-powered smartphone imaging system. Currently in U.S. pivotal trials.

Slit IQ™:An AI-powered remote examination platform for eye care specialists, enabling comprehensive anterior segment exams with clinical-grade standardization. It supports telemedicine and consistent monitoring of conditions like cataracts and uveitis. Currently in U.S. pivotal trials.

THERx IQ™:A wearable device for chronic eye diseases, focusing on personalized micro-dose medication delivery for glaucoma based on diurnal IOP data. It enhances efficacy, minimizes side effects, and removes compliance barriers. Currently in pilot trials.

miLens IQ+™:An AI/ML-powered platform integrating diurnal IOP monitoring and imaging data from miLens™ and Slit IQ™. It provides real-time risk stratification and predictive insights for early intervention across anterior segment diseases.

Specialties

Intraocular Pressure (IOP) Monitoring Anterior Segment Disease Management Microfluidic Technology AI-Enhanced Diagnostics Telemedicine Personalized Eye Care

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Bridge Round T: - FT: Bridge Round	A: 5200000 MR: - FA: $5.2 million FAN: 5200000	D: 2025-10-14 FD: 2025-10-14	5 investors
2	RT: Series A T: - FT: Series A	A: 6100000 MR: - FA: 6.1M FAN: 6100000	D: 2023-07-11 FD: 2023-07-11	8 investors

Bridge Round Latest

2025-10-14

$5.2M

5 investors (Pro only)

Series A 2023-07-11

$6.1M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Savas Komban

Co-Founder & Chief Executive Officer

LinkedIn (Pro only)

A

Ahmet Taylan Yazici

Co-Founder & Chief Medical Officer

S

Sevda Agaoglu

Co-Founder & Chief Scientific Officer

LinkedIn (Pro only)

S

Steve Klein

Head of Collaboration & Growth

B

Baris Ercal

Senior Scientist, Microfluidics

A

Ali Serbest

Head of ML and Software

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Smartlens, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised